Polydorou A A, Chisholm E M, Romanos A A, Dowsett J F, Cotton P B, Hatfield A R, Russell R C
Department of Gastroenterology, University College, Middlesex Hospital Medical School, London, UK.
Endoscopy. 1989 Nov;21(6):266-71. doi: 10.1055/s-2007-1012966.
Endoscopic endoprosthesis insertion plays an increasingly important role in the palliation of jaundice in patients with unresectable malignant hilar biliary obstruction (HBO). Drainage of both obstructed lobes in Types II and III HBO is not necessary to achieve adequate palliation, providing 25% of the liver volume is drained by a single endoprosthesis. The anatomy of the main hepatic ducts suggests some benefit may accrue from preferential drainage of the left hepatic duct. We have reviewed a consecutive series of 151 patients with Type II and III HBO over a 4-year period to compare the outcome of endoprosthesis placement in either the right (RHD) or left (LHD) hepatic duct, to test this hypothesis. No significant difference was found in terms of successful drainage, complications, 30-day mortality, number of endoprosthesis changes and survival between patients with right system drainage compared with those with left sided drainage (chi 2-test and Mann Whitney U test). When dealing with a patient with a Type II or III HBO, we would recommend single endoscopic endoprosthesis insertion into the technically most accessible obstructed system. This would achieve adequate palliation in 84% of the patients.
内镜下置入内支架在无法切除的恶性肝门部胆管梗阻(HBO)患者的黄疸姑息治疗中发挥着越来越重要的作用。对于II型和III型HBO患者,若单个内支架能引流25%的肝体积,则无需对双侧梗阻叶进行引流即可实现充分的姑息治疗。肝主管道的解剖结构提示,优先引流左肝管可能会带来一些益处。我们回顾了连续4年的151例II型和III型HBO患者,以比较在右肝管(RHD)或左肝管(LHD)置入内支架的效果,从而验证这一假设。结果发现,右肝管引流组与左肝管引流组在成功引流、并发症、30天死亡率、内支架更换次数及生存率方面无显著差异(卡方检验和曼-惠特尼U检验)。在处理II型或III型HBO患者时,我们建议将单个内镜下内支架置入技术上最易操作的梗阻系统。这将使84%的患者获得充分的姑息治疗。